ATRenew stock
RERENYSEATRenew Inc., Consumer CyclicalISIN US00138L1089
60Score 60 out of 100, Neutral
Price and trend
59 / 100
Price history
−8.1% in one yearThe chart shows daily closes over 5 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 14% below it.
Since May 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 51).
The price is 39% below its 52-week high. Largest decline in 5 years: 94% (June 2021 to February 2024).
Chart figures for advanced users
- SMA 50$3.96
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$4.49
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)51
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$3.62
- The lowest closing price of the last twelve months.
- Resistance$6.34
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- ATRenew Inc. belongs to the Specialty Retail industry (China) and, with a market value of $1.33B, is number 57 of 86 companies in its industry on MEQIRI.
- This is an American depositary receipt (ADR).
- MEQIRI Score 60 out of 100 (Neutral): rank 325 of 602 in Consumer Cyclical, median 61.
Show more
- The P/E is 19.3 (Specialty Retail median 23, own median of recent years 40.6).
- Our model puts fair value at $13.09, with the price 68% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 33.3% a year since 2020, Specialty Retail median 11%.Growth 70
- Analysts expect strong earnings growthUp 40.3% a year through 2028 (estimates from 3 analysts).Growth 70
- Below fair valuePrice 68% below the fair value of $13.09.Valuation 87
Weaknesses
- DilutionShare count up 66% since 2021.Capital allocation 51
- Negative free cash flowFree cash flow −$81.49M over the last 12 months.Fundamentals 39
- Volatile share priceVolatility 52% a year over the last 12 months.
Its standout strengths are valuation and stability, while fundamentals holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- price far below its 52-week high
Valuation
Valuation signal
Significantly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $9.35 and expensive above $21.81 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $21.58 (cash-flow model) and $4.60 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $11.22, at 6.3% it would be $15.90.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (23).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 30.3% on the twelve months before. Revenue has grown strongly since 2018, at around 30% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 12%, operating 2%, net 2%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 19 Nov 2026in 7 days
- Last reported
- 20 Aug 2026above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- 2.98+0.4%
- Revenue
- $4.05B+0.4%
- Earnings per share
- 4.2+0.4%
- Revenue
- $4.95B+0.4%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −9.4%Second quarter revenue above guidance; the company expects to maintain strong growth in both revenue and profit this year.
“Overall, we expect to maintain strong growth in both revenue and profit this year.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 20 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $19,048 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Zhu RuiSale
10 Jun 2026, Board
- Shares
- 4,762
- Price
- $4.00
- Value
- $19,048
Shares and prices per ordinary share as filed with the SEC, not per depositary receipt.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at ATRenew
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
602 rated companies in Consumer Cyclical
- This company
- 60
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Specialty Retail
The next larger and next smaller companies by market value
- RhRH $2.57B52
- ArhausARHS $2.06B70
- Sally Beauty HoldingsSBH $1.8B69
- Savers Value VillageSVV $1.52B64
- Liquidity ServicesLQDT $1.44B74
- National Vision HoldingsEYE $1.43B48
- Revolve GroupRVLV $1.41B60
- New Wave GroupNEWA-B.ST $1.4B65
ETFs that hold ATRenew
Held by 1 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Emerging Markets Equity UCITS ETF USD AccAVEM | 0.00% | 0.35% | €277.45M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 15 Aug 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.